BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35594710)

  • 1. Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats.
    Pan PH; Wang YY; Lin SY; Liao SL; Chen YF; Huang WC; Chen CJ; Chen WY
    Biomed Pharmacother; 2022 Jul; 151():113133. PubMed ID: 35594710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18β-Glycyrrhetinic Acid Protects against Cholestatic Liver Injury in Bile Duct-Ligated Rats.
    Pan PH; Wang YY; Lin SY; Liao SL; Chen YF; Huang WC; Chen CJ; Chen WY
    Antioxidants (Basel); 2022 May; 11(5):. PubMed ID: 35624826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model.
    Wang YY; Lin SY; Chen WY; Liao SL; Wu CC; Pan PH; Chou ST; Chen CJ
    J Ethnopharmacol; 2017 May; 204():58-66. PubMed ID: 28416441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
    Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
    J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats.
    Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ
    J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoprotective activities of rosmarinic acid against extrahepatic cholestasis in rats.
    Lin SY; Wang YY; Chen WY; Liao SL; Chou ST; Yang CP; Chen CJ
    Food Chem Toxicol; 2017 Oct; 108(Pt A):214-223. PubMed ID: 28789951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of rutin on liver injury induced by biliary obstruction in rats.
    Pan PH; Lin SY; Wang YY; Chen WY; Chuang YH; Wu CC; Chen CJ
    Free Radic Biol Med; 2014 Aug; 73():106-16. PubMed ID: 24815012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
    Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
    Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis.
    Liu J; Liu J; Meng C; Huang C; Liu F; Xia C
    Phytomedicine; 2022 Jul; 102():154173. PubMed ID: 35605478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
    Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
    Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
    Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
    Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W
    J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting HMGB1/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation.
    Nabih ES; El-Kharashi OA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jan; 392(1):37-43. PubMed ID: 30203151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway.
    Song G; Weng F; Zou B; Zhao J; Jin J; Yan D; Huang K; Sun X; Liu C; Hu Y; Li Y; Qiu F
    Clin Sci (Lond); 2023 Apr; 137(7):561-577. PubMed ID: 36795945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of quercetin on cholestatic liver injury.
    Lin SY; Wang YY; Chen WY; Chuang YH; Pan PH; Chen CJ
    J Nutr Biochem; 2014 Nov; 25(11):1183-1195. PubMed ID: 25108658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
    Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
    Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
    Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.
    Zhao SS; Li NR; Zhao WL; Liu H; Ge MX; Zhang YX; Zhao LY; You XF; He HW; Shao RG
    Acta Pharmacol Sin; 2018 Feb; 39(2):213-221. PubMed ID: 28748913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.